Drugs Online |
 |
 | ||
|
Ismo Retard Imdur |
|
| ||
Drugs Online » Prescription Drugs 9 » Ismo Retard Imdur This medication is a nitrate drug. It is used to prevent chest pain (angina) and reduce strain on the heart in patients with heart disease (coronary artery disease). Isosorbide mononitrate relaxes and widens blood vessels so blood can flow more easily.This medication will not relieve chest pain once it occurs. It is also not intended to be taken just before certain activities (e.g. exercise sexual intercourse) to prevent chest pain. Buy Ismo Retard Imdur and other Prescription Drugs 9 products online at Medstore. Buy Online at Medstore - Click Here!
About Ismo Retard Imdur: Product Type: Prescription Drugs 9 Ismo Retard (Imdur Generic Isosorbide Mononitrate) Ismo Retard (Imdur Generic Isosorbide Mononitrate) Imdur Generic Isosorbide Mononitrate 40mg 84 Tablets 2 x 84 Tablets 4 x 84 Tablets Imdur Generic Isosorbide Mononitrate Ismo Retard
View more Prescription Drugs 9 Drugs Online: From Gulf News: Runners should avoid prescription drugs. Statins may increase production of the enzyme creatine kinase, and hence heighten chances of muscle damage in athletes. Marathon running has increased in popularity over the past three decades, with participation in the United States rising from 25,000 runners in 1976 to nearly 470,000 in 2008. Many professional and recreational runners take prescription drugs, unaware of potential side-effects that affect runners in particular. One such class of drugs, called statins, which includes medicines such as Lipitor, Crestor and Pravachol, lowers blood cholesterol by inhibiting a cholesterol-producing enzyme and may even lower the risks of heart attack and further cardiovascular disease in a narrow category of patients. A new study forthcoming in the American Journal of Cardiology examined the effect of statins on creatine kinase (CK), an enzyme linked to muscle damage. Elevated levels of CK in the blood and muscle after exercise correlates with muscle damage. The study, conducted by Dr Beth Parker of the Henry Low Heart Centre at Connecticut's Hartford Hospital, is the first to measure CK levels in athletes taking statins after physical activity in a real-life environment rather than in a university laboratory.
| ||
